Cargando…
Probing the Meaning of Persistent Propeptide Release in Type 1 Diabetes
Autores principales: | Kahn, Steven E., Templin, Andrew T., Hull, Rebecca L., Verchere, C. Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341289/ https://www.ncbi.nlm.nih.gov/pubmed/30665962 http://dx.doi.org/10.2337/dci18-0054 |
Ejemplares similares
-
A small molecule improves diabetes in mice expressing human islet amyloid polypeptide
por: Bhagat, Vriti, et al.
Publicado: (2023) -
C-peptide persistence in type 1 diabetes: ‘not drowning, but waving’?
por: Leslie, R. David, et al.
Publicado: (2019) -
Persistent Organic Pollutants and Obesity-Related Metabolic Dysfunction: Focusing on Type 2 Diabetes
por: Lee, Duk-Hee
Publicado: (2012) -
Propeptide-Mediated Inhibition of Cognate Gingipain Proteinases
por: Huq, N. Laila, et al.
Publicado: (2013) -
Propeptide genesis by Kex2-dependent cleavage of yeast wall protein 1 (Ywp1) of Candida albicans
por: Granger, Bruce L.
Publicado: (2018)